To Invest or Divest – Tough Choices in the Wake of VEST

Recently a patient of mine, a middle-aged woman with chemotherapy-induced cardiomyopathy and moderate left ventricular systolic dysfunction, was admitted to a local hospital with acute decompensated heart failure (HF), where an echocardiogram reportedly demonstrated an ejection fraction (EF) of 15%. In addition to treating her HF, they slapped a LifeVest (ZOLL) on her and told her to see her regular cardiologist (me) as soon as possible. Several months later she showed up in my office – still wearing the LifeVest.

Source: Journal of Cardiac Failure - October 1, 2018 Category: Cardiology Authors: Michael W. Rich Source Type: research